![Richard D. Katz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard D. Katz
Plus aucun poste en cours
Profil
Richard D.
Katz served as CFO, Executive VP-Finance & Corporate Development at Neusentis, Inc. He also held the position of Chief Financial Officer at Liquidia Technologies, Inc., Icagen, Inc., and Argos Therapeutics, Inc. Additionally, he was the Chief Financial & Business Officer at Viamet Pharmaceuticals, Inc. and Viamet Pharmaceuticals Corp.
Prior to these roles, he worked as a Vice President at Goldman Sachs & Co. LLC.
Katz holds an undergraduate degree from Harvard University, a doctorate from Stanford University School of Medicine, and an MBA from Harvard Business School.
Anciens postes connus de Richard D. Katz
| Sociétés | Poste | Fin |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 02/09/2022 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Directeur Financier/CFO | 20/08/2020 |
| LIQUIDIA CORPORATION | Directeur Financier/CFO | 01/08/2020 |
| ARGOS THERAPEUTICS, INC. | Directeur Financier/CFO | 30/11/2018 |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Directeur Financier/CFO | 01/05/2016 |
Formation de Richard D. Katz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Health Technology |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Allena Pharmaceuticals, Inc.
 Allena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and retails drugs through online | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Choisissez Zonebourse 
